Original Research
Accepted on 06 Oct 2025
Anti-convulsant efficacy of long-acting injectable cannabidiol formulation (IVL5005) in the pentylenetetrazol-induced convulsions, with pharmacokinetic characterization
in Experimental Pharmacology and Drug Discovery